Literature DB >> 18631971

Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study.

Majid Fotuhi1, Peter P Zandi, Kathleen M Hayden, Ara S Khachaturian, Christine A Szekely, Heidi Wengreen, Ronald G Munger, Maria C Norton, Joann T Tschanz, Constantine G Lyketsos, John C S Breitner, Kathleen Welsh-Bohmer.   

Abstract

Studies have shown less cognitive decline and lower risk of Alzheimer's disease in elderly individuals consuming either antioxidant vitamins or nonsteroidal anti-inflammatory drugs (NSAIDs). The potential of added benefit from their combined use has not been studied. We therefore analyzed data from 3,376 elderly participants of the Cache County Study who were given the Modified Mini-Mental State examination up to three times during a period of 8 years. Those who used a combination of vitamins E and C supplements and NSAIDs at baseline declined by an average 0.96 fewer points every 3 years than nonusers (P < .05). This apparent effect was attributable entirely to participants with the APOE epsilon4 allele, whose users declined by 2.25 fewer points than nonusers every 3 years (P < .05). These results suggest that among elderly individuals with an APOE epsilon4 allele, there is an association between using antioxidant supplements in combination with NSAIDs and less cognitive decline over time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631971      PMCID: PMC2684982          DOI: 10.1016/j.jalz.2008.01.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  12 in total

1.  Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

Authors:  J C Breitner; P P Zandi
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

2.  Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.

Authors:  R A Miech; J C S Breitner; P P Zandi; A S Khachaturian; J C Anthony; L Mayer
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

3.  Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.

Authors:  S A Frautschy; W Hu; P Kim; S A Miller; T Chu; M E Harris-White; G M Cole
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 4.  Oxidative stress and neurodegeneration: where are we now?

Authors:  Barry Halliwell
Journal:  J Neurochem       Date:  2006-06       Impact factor: 5.372

Review 5.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

Authors:  Patricia McGettigan; David Henry
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

Review 6.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

7.  An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study.

Authors:  JoAnn T Tschanz; Kathleen A Welsh-Bohmer; Brenda L Plassman; Maria C Norton; Bonita W Wyse; John C S Breitner
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2002-03

8.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01

9.  Antioxidant intake and cognitive function of elderly men and women: the Cache County Study.

Authors:  H J Wengreen; R G Munger; C D Corcoran; P Zandi; K M Hayden; M Fotuhi; I Skoog; M C Norton; J Tschanz; J C S Breitner; K A Welsh-Bohmer
Journal:  J Nutr Health Aging       Date:  2007 May-Jun       Impact factor: 4.075

10.  Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.

Authors:  Sascha Weggen; Jason L Eriksen; Sarah A Sagi; Claus U Pietrzik; Victor Ozols; Abdul Fauq; Todd E Golde; Edward H Koo
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

View more
  22 in total

Review 1.  Diet and neurocognition: review of evidence and methodological considerations.

Authors:  Patrick J Smith; James A Blumenthal
Journal:  Curr Aging Sci       Date:  2010-02

Review 2.  Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.

Authors:  Greg M Cole; Sally A Frautschy
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

Review 3.  A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease.

Authors:  Fiona E Harrison
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  A derangement of the brain wound healing process may cause some cases of Alzheimer's disease.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2016-08       Impact factor: 2.970

Review 5.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

6.  Vitamin C Supplementation, APOE4 Genotype and Cognitive Functioning in a Rural-Dwelling Cohort.

Authors:  K Chaudhari; N Sumien; L Johnson; D D'Agostino; M Edwards; R J Paxton; J R Hall; S O'Bryant
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

7.  NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease.

Authors:  Magdalena Sastre; Steve M Gentleman
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

8.  Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Authors:  F E Harrison; J Allard; R Bixler; C Usoh; L Li; J M May; M P McDonald
Journal:  Nutr Neurosci       Date:  2009-10       Impact factor: 4.994

9.  Genetic aspects of behavioral neurotoxicology.

Authors:  Edward D Levin; Michael Aschner; Ulrike Heberlein; Douglas Ruden; Kathleen A Welsh-Bohmer; Selena Bartlett; Karen Berger; Lang Chen; Ammon B Corl; Donnie Eddins; Rachael French; Kathleen M Hayden; Kirsten Helmcke; Helmut V B Hirsch; Elwood Linney; Greg Lnenicka; Grier P Page; Debra Possidente; Bernard Possidente; Annette Kirshner
Journal:  Neurotoxicology       Date:  2009-07-30       Impact factor: 4.294

Review 10.  Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.

Authors:  C H Latta; H M Brothers; D M Wilcock
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.